- Home
- XAIR
XAIR
Beyond Air Inc.
as 05-09-2025 12:46pm EST
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | GARDEN CITY |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $1.50 | AVG Volume (30 days): | 3.1M |
| Analyst Decision: | Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.96 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.19 - $1.49 | Next Earning Date: | 06-23-2025 |
| Revenue: | $3,023,000 | Revenue Growth: | 338.75% |
| Revenue Growth (this year): | 244.61% | Revenue Growth (next year): | 258.76% |
Stock Insider Trading Activity of Beyond Air Inc. (XAIR)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Carey Robert | XAIR | Director | Mar 14 '25 | Buy | $0.25 | 1,000,000 | $250,050.00 | 4,066,864 | |
| Gaul Michael A. | XAIR | Chief Operating Officer | Feb 19 '25 | Buy | $0.38 | 6,000 | $2,293.80 | 94,150 |
Latest Beyond Air Inc. News
XAIR Breaking Stock News: Dive into XAIR Ticker-Specific Updates for Smart Investing
GlobeNewswire
15 days ago
Beyond Air Granted U.S. Patent Covering Treatment of NTM Infections Using gaseous Nitric Oxide (gNO)
GlobeNewswire
18 days ago
NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism
GlobeNewswire
24 days ago
NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board
GlobeNewswire
a month ago
Beyond Air Publishes Article in Annals of the American Thoracic Society Journal Highlighting NTM-PD Patients’ Ability to Safely Self-Administer High-Dose Intermittent iNO Treatments Using the LungFit™ GO at Home
GlobeNewswire
a month ago
NeuroNOS Announces Groundbreaking Research Publication by its CSO Demonstrating Mechanism of Action in Alzheimer’s Disease and Reinforcing Platform’s Strength Across Neurological Disorders
GlobeNewswire
a month ago
Beyond Air Announces Vanderbilt University Medical Center as First Luminary Site
GlobeNewswire
a month ago
NeuroNOS Secures $2.0 Million in Funding to Advance Development of an Innovative Autism Therapy
GlobeNewswire
2 months ago
Beyond Air Announces Agreements Expanding Global Distribution of LungFit® PH
Compare XAIR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "XAIR Beyond Air Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.